BusinessExosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate®(IntelliScore) (EPI) TestBy Nasdaq OMXMay 8, 2018, 10:30 AM UTC
BusinessCapricor to Present on Exosomes at the Plenary Session of the International Society for Cellular Therapy in MontrealBy Nasdaq OMXMay 3, 2018, 11:01 AM UTC
BusinessExosome Diagnostics Appoints Accomplished Urologist, Grannum Sant, MD, FRCS, FACS, as Head of Medical AffairsBy Nasdaq OMXMar 21, 2018, 11:41 AM UTC
BusinessExosome Diagnostics Announces Publication of a Highly Sensitive Exosome Based Liquid Biopsy Test for EGFR T790M Mutations in Plasma from Non-Small Cell Lung Cancer PatientsBy Nasdaq OMXMar 20, 2018, 11:46 AM UTC
BusinessExosome Diagnostics Partners with Intezyne to Develop Exosomal RNA-based Assay for Novel Cancer Resistance Pathway (CRP) InhibitorBy Nasdaq OMXMar 14, 2018, 11:30 AM UTC
BusinessExosome Diagnostics Places Early Access Shahky™ Exosomal Protein Detection System at MGH Center for Systems BiologyBy Nasdaq OMXJan 9, 2018, 12:46 PM UTC
BusinessExosome Diagnostics Places Its First Early Access Shahky System within a Top 15 Pharmaceutical LaboratoryBy Nasdaq OMXJan 8, 2018, 12:56 PM UTC
